These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 18790559)

  • 41. Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines.
    Yoshizawa K; Cioca DP; Kawa S; Tanaka E; Kiyosawa K
    Cancer; 2002 Nov; 95(10):2243-51. PubMed ID: 12412180
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peroxisome proliferator-activated receptor gamma-independent effects of thiazolidinediones on human cardiac myofibroblast function.
    Mughal RS; Warburton P; O'Regan DJ; Ball SG; Turner NA; Porter KE
    Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):478-86. PubMed ID: 19673929
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Troglitazone inhibits cell growth and induces apoptosis of B-cell acute lymphoblastic leukemia cells with t(14;18).
    Takenokuchi M; Saigo K; Nakamachi Y; Kawano S; Hashimoto M; Fujioka T; Koizumi T; Tatsumi E; Kumagai S
    Acta Haematol; 2006; 116(1):30-40. PubMed ID: 16809887
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacological exploitation of the peroxisome proliferator-activated receptor gamma agonist ciglitazone to develop a novel class of androgen receptor-ablative agents.
    Yang J; Wei S; Wang DS; Wang YC; Kulp SK; Chen CS
    J Med Chem; 2008 Apr; 51(7):2100-7. PubMed ID: 18335975
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Troglitazone sensitizes effect of epirubicin on breast cancer cells].
    Sun JX; Meng ZX; Lv JH; Sun YJ
    Ai Zheng; 2006 Aug; 25(8):960-6. PubMed ID: 16965675
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.
    Cheon CW; Kim DH; Kim DH; Cho YH; Kim JH
    World J Gastroenterol; 2009 Jan; 15(3):310-20. PubMed ID: 19140230
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Thiazolidinedione insulin sensitizers alter lipid bilayer properties and voltage-dependent sodium channel function: implications for drug discovery.
    Rusinova R; Herold KF; Sanford RL; Greathouse DV; Hemmings HC; Andersen OS
    J Gen Physiol; 2011 Aug; 138(2):249-70. PubMed ID: 21788612
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proline oxidase, a proapoptotic gene, is induced by troglitazone: evidence for both peroxisome proliferator-activated receptor gamma-dependent and -independent mechanisms.
    Pandhare J; Cooper SK; Phang JM
    J Biol Chem; 2006 Jan; 281(4):2044-52. PubMed ID: 16303758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling.
    Yan J; Yang H; Wang G; Sun L; Zhou Y; Guo Y; Xi Z; Jiang X
    Autophagy; 2010 Jan; 6(1):67-73. PubMed ID: 19923924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel high-affinity PPARgamma agonist alone and in combination with paclitaxel inhibits human anaplastic thyroid carcinoma tumor growth via p21WAF1/CIP1.
    Copland JA; Marlow LA; Kurakata S; Fujiwara K; Wong AK; Kreinest PA; Williams SF; Haugen BR; Klopper JP; Smallridge RC
    Oncogene; 2006 Apr; 25(16):2304-17. PubMed ID: 16331265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Troglitazone induced apoptosis via PPARγ activated POX-induced ROS formation in HT29 cells.
    Wang J; Lv X; Shi J; Hu X; DU Y
    Biomed Environ Sci; 2011 Aug; 24(4):391-9. PubMed ID: 22108328
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Peroxisome proliferator-activated receptor gamma agonists promote TRAIL-induced apoptosis by reducing survivin levels via cyclin D3 repression and cell cycle arrest.
    Lu M; Kwan T; Yu C; Chen F; Freedman B; Schafer JM; Lee EJ; Jameson JL; Jordan VC; Cryns VL
    J Biol Chem; 2005 Feb; 280(8):6742-51. PubMed ID: 15569667
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of ligand troglitazone on peroxisome proliferator-activated receptor gamma expression and cellular growth in human colon cancer cells.
    Ming M; Yu JP; Meng XZ; Zhou YH; Yu HG; Luo HS
    World J Gastroenterol; 2006 Dec; 12(45):7263-70. PubMed ID: 17143939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D; Yin F; Liu J; Berger JP; Sakai T; Blaschke F; Fleck E; Van Herle AJ; Forman BM; Law RE
    Circ Res; 2003 Aug; 93(4):e38-47. PubMed ID: 12881480
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Troglitazone, a PPAR agonist, inhibits human prostate cancer cell growth through inactivation of NFκB via suppression of GSK-3β expression.
    Ban JO; Oh JH; Son SM; Won D; Song HS; Han SB; Moon DC; Kang KW; Song MJ; Hong JT
    Cancer Biol Ther; 2011 Aug; 12(4):288-96. PubMed ID: 21613824
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A selective peroxisome proliferator-activated receptor-gamma modulator, telmisartan, binds to the receptor in a different fashion from thiazolidinediones.
    Tagami T; Yamamoto H; Moriyama K; Sawai K; Usui T; Shimatsu A; Naruse M
    Endocrinology; 2009 Feb; 150(2):862-70. PubMed ID: 19147680
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Troglitazone inhibits histone deacetylase activity in breast cancer cells.
    Davies GF; Ross AR; Arnason TG; Juurlink BH; Harkness TA
    Cancer Lett; 2010 Feb; 288(2):236-50. PubMed ID: 19699029
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antitumor activity of a novel series of alpha-aryloxy-alpha-methylhydrocinnamic acid derivatives as PPAR gamma agonists against a panel of human cancer cell lines.
    Xiong X; Ye Y; Fu L; Dai B; Liu J; Jia J; Tang J; Li L; Wang L; Shen J; Mei C
    Invest New Drugs; 2009 Jun; 27(3):223-32. PubMed ID: 18704263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines.
    Park JW; Zarnegar R; Kanauchi H; Wong MG; Hyun WC; Ginzinger DG; Lobo M; Cotter P; Duh QY; Clark OH
    Thyroid; 2005 Mar; 15(3):222-31. PubMed ID: 15785241
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The peroxisome proliferator-activated receptor gamma ligand troglitazone induces apoptosis and p53 in rat granulosa cells.
    Lovekamp-Swan T; Chaffin CL
    Mol Cell Endocrinol; 2005 Apr; 233(1-2):15-24. PubMed ID: 15767042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.